Cargando…
Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology
PURPOSE: Adjuvant chemotherapy within 56 or 84 days following curative resection is globally accepted as the standard of care for stage III colon cancer as it has been associated with improved overall survival. Initiation of adjuvant chemotherapy within this time frame is therefore recommended by cl...
Autores principales: | Elkrief, Arielle, Redstone, Genevieve, Petruccelli, Luca, Ali, Alla'a, Thomas, Doneal, Fernandez, Myriam, Rousseau, Caroline, Aleynikova, Olga, Anderson, Dawn, Ghitulescu, Gabriela, Vasilevsky, Carol-Ann, Dalfen, Richard, Langleben, Adrian, Liberman, Sender, Kavan, Petr, Alcindor, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942255/ https://www.ncbi.nlm.nih.gov/pubmed/33685857 http://dx.doi.org/10.1136/bmjoq-2020-000934 |
Ejemplares similares
-
McGill University
Publicado: (1896) -
McGill University
Publicado: (1896) -
McGill University
por: Parker, J. M.
Publicado: (1895) -
McGill University
Publicado: (1895) -
Dr. William D. McGill
Publicado: (1911)